Latest News | Marksans Pharma Gets UK MHRA Nod for Diarrhea Medication
Get latest articles and stories on Latest News at LatestLY. Drug firm Marksans Pharma on Thursday said its subsidiary has received market authorisation from the UK health regulator for its anti-diarrhoea medication Loperamide capsules.
New Delhi, Dec 9 (PTI) Drug firm Marksans Pharma on Thursday said its subsidiary has received market authorisation from the UK health regulator for its anti-diarrhoea medication Loperamide capsules.
The UK MHRA has granted market authorisation to the company's wholly-owned subsidiary Relonchem Ltd for Loperamide hard capsules (2mg), Marksans Pharma said in a regulatory filing.
Also Read | India's COVID-19 Vaccination Coverage Crosses 131 Crore Doses.
Marksans Pharma said it will manufacture the product at its Goa-based oral dosage facility.
(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)